Einari Aavik

2.7k total citations
46 papers, 1.5k citations indexed

About

Einari Aavik is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Einari Aavik has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Surgery and 11 papers in Immunology. Recurrent topics in Einari Aavik's work include Renal Transplantation Outcomes and Treatments (7 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Transplantation: Methods and Outcomes (6 papers). Einari Aavik is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Transplantation: Methods and Outcomes (6 papers). Einari Aavik collaborates with scholars based in Finland, United States and South Africa. Einari Aavik's co-authors include Seppo Ylä‐Herttuala, P Häyry, Kai Krohn, Mikko P. Turunen, Pärt Peterson, Raivo Uibo, Marjukka Myllärniemi, E Taskinen, Leena Strauss and Sari Mäkelä and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Einari Aavik

45 papers receiving 1.5k citations

Peers

Einari Aavik

GENET

EDM

IMMUN

SURGE

Yasuyuki Okamoto Japan

María Eugenia Sáez Spain

Yoko Yoshida Japan

Edward J. Keenan United States

S. Hauptmann Germany

V. Bonnevie‐Nielsen Denmark

Takuma Hayashi Japan

Carolyn D. Scott Australia

Jean-Michel Foidart Belgium

Yasuyuki Okamoto Japan

Einari Aavik

532 ×0.9

218 ×0.5

GENET

324 ×0.8

EDM

175 ×0.7

IMMUN

246 ×1.1

SURGE

Citations per year, relative to Einari Aavik Einari Aavik (= 1×) peers Yasuyuki Okamoto

Countries citing papers authored by Einari Aavik

Since Specialization

Citations

This map shows the geographic impact of Einari Aavik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einari Aavik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einari Aavik more than expected).

Fields of papers citing papers by Einari Aavik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einari Aavik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einari Aavik. The network helps show where Einari Aavik may publish in the future.

Co-authorship network of co-authors of Einari Aavik

This figure shows the co-authorship network connecting the top 25 collaborators of Einari Aavik. A scholar is included among the top collaborators of Einari Aavik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einari Aavik. Einari Aavik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niskanen, Henri, Ilya Skovorodkin, Ilakya Selvarajan, et al.. (2024). Translatome profiling reveals Itih4 as a novel smooth muscle cell–specific gene in atherosclerosis. Cardiovascular Research. 120(8). 869–882. 9 indexed citations

Niskanen, Henri, et al.. (2023). Hypoxic regulation of hypoxia inducible factor 1 alpha via antisense transcription. Journal of Biological Chemistry. 299(11). 105291–105291. 3 indexed citations

Örd, Tiit, Tapio Lönnberg, Henri Niskanen, et al.. (2023). Dissecting the polygenic basis of atherosclerosis via disease-associated cell state signatures. The American Journal of Human Genetics. 110(5). 722–740. 21 indexed citations

Aavik, Einari, et al.. (2021). Epigenetic Regulation of Vascular Smooth Muscle Cell Phenotype Switching in Atherosclerotic Artery Remodeling: A Mini-Review. Frontiers in Genetics. 12. 719456–719456. 22 indexed citations

Gurzeler, Erika, Einari Aavik, Henri Niskanen, et al.. (2018). Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(2). 481–490. 2 indexed citations

Aavik, Einari, Mohan Babu, & Seppo Ylä‐Herttuala. (2018). DNA methylation processes in atherosclerotic plaque. Atherosclerosis. 281. 168–179. 54 indexed citations

Örd, Tiit, Henri Niskanen, Maria Bouvy‐Liivrand, et al.. (2018). Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells. Frontiers in Cardiovascular Medicine. 5. 159–159. 26 indexed citations

Aavik, Einari, Olli Leppänen, Sanna-Kaisa Häkkinen, et al.. (2014). Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. European Heart Journal. 36(16). 993–1000. 96 indexed citations

Aavik, Einari, et al.. (2008). Mechanisms behind the Synergistic Effect of Sirolimus and Imatinib in Preventing Restenosis after Intimal Injury. Journal of Vascular Research. 46(3). 240–252. 6 indexed citations

10.

Aavik, Einari, et al.. (2007). Vasculoprotective effects of somatostatin receptor subtypes. Molecular and Cellular Endocrinology. 279(1-2). 34–38. 5 indexed citations

11.

Vamvakopoulos, Joannis, et al.. (2006). Synergistic Suppression of Rat Neointimal Hyperplasia by Rapamycin and Imatinib Mesylate: Implications for the Prevention of Accelerated Arteriosclerosis. Journal of Vascular Research. 43(2). 184–192. 10 indexed citations

12.

Häyry, P, et al.. (2001). Molecular biology of transplant arteriosclerosis and sites of therapeutic intervention. Transplantation Proceedings. 33(1-2). 293–294. 1 indexed citations

13.

Frösén, Juhana, et al.. (2001). Expression of estrogen receptor sub-types α and β in acute and chronic cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 20(12). 1252–1264. 16 indexed citations

14.

Aavik, Einari, et al.. (2001). Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury. Molecular and Cellular Endocrinology. 182(1). 91–98. 27 indexed citations

15.

Häyry, P, et al.. (2000). Emerging therapeutic strategies for the prevention and treatment of chronic allograft rejection. Transplantation Proceedings. 32(3). 519–519. 2 indexed citations

16.

Aavik, Einari, et al.. (1999). Role of Platelet-derived Growth Factor in Obliterative Bronchiolitis (Chronic Rejection) in the Rat. American Journal of Respiratory and Critical Care Medicine. 160(4). 1324–1332. 44 indexed citations

17.

Häyry, P, Marjukka Myllärniemi, Lorena Ramírez, et al.. (1997). Immunobiology and pathology of chronic rejection. Transplantation Proceedings. 29(1-2). 77–78. 11 indexed citations

18.

Häyry, P, et al.. (1997). Role of growth factors in graft vessel disease. Transplantation Proceedings. 29(6). 2551–2551. 8 indexed citations

19.

Häyry, P, Einari Aavik, & Marjukka Myllärniemi. (1996). Blockade of growth factor synthesis and growth factor action: Two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury. Metabolism. 45(8 Suppl 1). 101–103. 13 indexed citations

20.

Peterson, Pärt, Jukka Partanen, Einari Aavik, et al.. (1995). Steroid 21‐hydroxylase gene polymorphism in Addison's disease patients. Tissue Antigens. 46(1). 63–67. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact